Global Plasma Protein Therapeutics Competitive Landscape Professional Research Report 2024

Global Plasma Protein Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Plasma protein therapeutics refers to a category of medical treatments derived from human plasma proteins, which are isolated and purified to produce therapeutic products. These proteins play essential roles in various physiological processes, and when deficient or dysfunctional, they can lead to medical conditions. Plasma protein therapeutics include a range of products such as clotting factors for hemophilia, immunoglobulins for immune disorders, albumin for maintaining blood volume, and other proteins involved in coagulation and immune response. These therapies are typically administered through intravenous infusion to patients with congenital or acquired disorders affecting the production or function of specific proteins. Plasma protein therapeutics have revolutionized the treatment of various rare diseases, providing life-saving and life-sustaining interventions for individuals with conditions that were once challenging to manage effectively. The production of these therapeutics involves the plasma fractionation process, where plasma is separated into its constituent parts, and specific proteins are isolated and purified for therapeutic use.

According to DIResearch's in-depth investigation and research, the global Plasma Protein Therapeutics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Plasma Protein Therapeutics include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Plasma Protein Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Protein Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Protein Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Protein Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Plasma Protein Therapeutics Include:

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

Plasma Protein Therapeutics Product Segment Include:

Coagulation Factor

Immune Globulin

Albumin

Others

Plasma Protein Therapeutics Product Application Include:

Hemophilia

Pelvic inflammatory disease (PID)

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Plasma Protein Therapeutics Industry PESTEL Analysis

Chapter 3: Global Plasma Protein Therapeutics Industry Porter’s Five Forces Analysis

Chapter 4: Global Plasma Protein Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Plasma Protein Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Plasma Protein Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Plasma Protein Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources